METTL3 and neoplasm: Among all HATs tested (Supplementary Fig. 2b), only ectopic p300 completely blunted migration/invasion of METTL3-expressing cells (Fig. 2c, d), demonstrating that p300 counteracts with METTL3 in promoting tumor cell invasiveness via catalyzing its acetylation.